FDA Pushes Enrollment of Underrepresented Populations in Clinical Trials with Recent ‘Race and Ethnicity Diversity Plan’ Draft Guidance
Jacob Simpson , Breazeale Sachse & Wilson LLP The U.S. Food and Drug Administration (FDA) recently published […]